← All organizations

TargeGen

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 1, 2008

Acquired by Sanofi-Aventis on Jun 30, 2010

Timeline

2000s

Jun 1, 2002
TargeGen— Founded

2010s

Jun 30, 2010
Sanofi-Aventis— Acquired By

Drugs by trial phase (3 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

fedratinib

Indications

Studied for

Recent trials (4)

NCT00631462Lead sponsorPhase 1Jan 1, 2008
NCT00509548Lead sponsorPhase 2Jul 1, 2007
NCT00414999Lead sponsorPhase 1Nov 1, 2006
NCT00103350Lead sponsorPhase 1/Phase 2Jan 1, 2005

Details

Founded: San Diego, CA, US Jun 1, 2002
Last known activity: Jan 1, 2008